Free Trial

IGM Biosciences (IGMS) Competitors

$11.91
+0.21 (+1.79%)
(As of 07/17/2024 ET)

IGMS vs. CYRX, ZNTL, AUPH, XNCR, KROS, JANX, MRVI, PTGX, EWTX, and VERA

Should you be buying IGM Biosciences stock or one of its competitors? The main competitors of IGM Biosciences include Cryoport (CYRX), Zentalis Pharmaceuticals (ZNTL), Aurinia Pharmaceuticals (AUPH), Xencor (XNCR), Keros Therapeutics (KROS), Janux Therapeutics (JANX), Maravai LifeSciences (MRVI), Protagonist Therapeutics (PTGX), Edgewise Therapeutics (EWTX), and Vera Therapeutics (VERA). These companies are all part of the "pharmaceutical preparations" industry.

IGM Biosciences vs.

IGM Biosciences (NASDAQ:IGMS) and Cryoport (NASDAQ:CYRX) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, community ranking, dividends, institutional ownership, risk and earnings.

42.8% of IGM Biosciences shares are held by institutional investors. Comparatively, 92.9% of Cryoport shares are held by institutional investors. 57.0% of IGM Biosciences shares are held by insiders. Comparatively, 10.1% of Cryoport shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

IGM Biosciences presently has a consensus target price of $17.89, suggesting a potential upside of 50.20%. Cryoport has a consensus target price of $19.43, suggesting a potential upside of 129.38%. Given Cryoport's higher probable upside, analysts plainly believe Cryoport is more favorable than IGM Biosciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IGM Biosciences
0 Sell rating(s)
4 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50
Cryoport
0 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

IGM Biosciences has a beta of 0.2, suggesting that its stock price is 80% less volatile than the S&P 500. Comparatively, Cryoport has a beta of 1.59, suggesting that its stock price is 59% more volatile than the S&P 500.

In the previous week, Cryoport had 1 more articles in the media than IGM Biosciences. MarketBeat recorded 5 mentions for Cryoport and 4 mentions for IGM Biosciences. IGM Biosciences' average media sentiment score of 0.78 beat Cryoport's score of 0.72 indicating that IGM Biosciences is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
IGM Biosciences
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cryoport
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Cryoport received 175 more outperform votes than IGM Biosciences when rated by MarketBeat users. Likewise, 65.21% of users gave Cryoport an outperform vote while only 48.84% of users gave IGM Biosciences an outperform vote.

CompanyUnderperformOutperform
IGM BiosciencesOutperform Votes
63
48.84%
Underperform Votes
66
51.16%
CryoportOutperform Votes
238
65.21%
Underperform Votes
127
34.79%

Cryoport has higher revenue and earnings than IGM Biosciences. Cryoport is trading at a lower price-to-earnings ratio than IGM Biosciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IGM Biosciences$2.13M330.01-$246.42M-$4.31-2.76
Cryoport$233.26M1.79-$99.59M-$2.47-3.43

Cryoport has a net margin of -50.17% compared to IGM Biosciences' net margin of -11,255.25%. Cryoport's return on equity of -15.19% beat IGM Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
IGM Biosciences-11,255.25% -108.07% -54.01%
Cryoport -50.17%-15.19%-7.50%

Summary

Cryoport beats IGM Biosciences on 12 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IGMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IGMS vs. The Competition

MetricIGM BiosciencesPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$702.93M$7.18B$5.30B$8.52B
Dividend YieldN/A2.75%2.76%4.02%
P/E Ratio-2.7617.89128.7817.99
Price / Sales330.01483.072,248.76106.83
Price / CashN/A33.3235.2733.66
Price / Book3.445.934.984.55
Net Income-$246.42M$147.02M$110.48M$216.32M
7 Day Performance69.90%6.28%5.37%5.84%
1 Month Performance62.93%8.23%8.09%7.15%
1 Year Performance16.20%-1.57%6.30%3.50%

IGM Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CYRX
Cryoport
3.2148 of 5 stars
3.21 / 5 stars
$7.03
+26.7%
$18.25
+159.6%
-46.5%$346.30M$233.26M-2.851,170Short Interest ↓
Gap Down
High Trading Volume
ZNTL
Zentalis Pharmaceuticals
2.9745 of 5 stars
2.97 / 5 stars
$3.98
+1.0%
$11.33
+184.8%
-84.4%$282.70MN/A-1.20124Gap Up
AUPH
Aurinia Pharmaceuticals
2.0045 of 5 stars
2.00 / 5 stars
$5.86
+6.5%
$10.00
+70.6%
-48.1%$835.99M$175.51M-13.63300Positive News
XNCR
Xencor
4.088 of 5 stars
4.09 / 5 stars
$19.39
+4.0%
$35.38
+82.4%
-19.0%$1.20B$168.34M-8.85280Positive News
KROS
Keros Therapeutics
2.5692 of 5 stars
2.57 / 5 stars
$45.97
+6.9%
$88.29
+92.1%
+18.4%$1.66B$234,000.00-8.93141News Coverage
Positive News
Gap Down
JANX
Janux Therapeutics
2.1185 of 5 stars
2.12 / 5 stars
$42.28
+1.8%
$66.29
+56.8%
+262.3%$2.19B$8.08M-34.6668Gap Down
MRVI
Maravai LifeSciences
3.1666 of 5 stars
3.17 / 5 stars
$8.60
+11.4%
$11.44
+33.1%
-25.8%$2.17B$274.10M-8.69650
PTGX
Protagonist Therapeutics
2.0218 of 5 stars
2.02 / 5 stars
$35.79
+2.9%
$38.00
+6.2%
+70.2%$2.10B$60M14.67112Positive News
EWTX
Edgewise Therapeutics
1.3852 of 5 stars
1.39 / 5 stars
$22.33
+3.8%
$33.20
+48.7%
+195.6%$2.09BN/A-14.4192Gap Up
VERA
Vera Therapeutics
1.1708 of 5 stars
1.17 / 5 stars
$37.57
+2.8%
$42.86
+14.1%
+106.9%$2.06BN/A-18.3351News Coverage
Positive News

Related Companies and Tools

This page (NASDAQ:IGMS) was last updated on 7/18/2024 by MarketBeat.com Staff

From Our Partners